Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 96,652 | 76,199 | 75,208 | 69,582 | 214,521 |
| Depreciation Amortization | -925 | 580 | 375 | 180 | 603 |
| Accounts receivable | 3,988 | -1,243 | -374 | 205 | -3,344 |
| Accounts payable and accrued liabilities | 2,761 | 5,403 | 6,447 | 5,465 | 2,280 |
| Other Working Capital | -228,481 | -176,475 | -139,860 | -97,957 | 284,222 |
| Other Operating Activity | 14,812 | 11,516 | 3,880 | -1,477 | 14,858 |
| Operating Cash Flow | $-111,193 | $-84,020 | $-54,324 | $-24,002 | $513,140 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -120 | -121 | -99 | -96 | -61 |
| PPE Investments | -938 | -821 | -738 | -227 | -1,181 |
| Purchase Of Investment | -445,004 | N/A | 0 | N/A | N/A |
| Investing Cash Flow | $-446,062 | $-942 | $-837 | $-323 | $-1,242 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,059 | N/A | N/A | N/A | 716 |
| Common Stock Issued | 925 | 610 | 611 | 333 | 2,943 |
| Financing Cash Flow | $1,984 | $610 | $611 | $333 | $3,659 |
| Exchange Rate Effect | -8,526 | -12,014 | -2,134 | -563 | -3,176 |
| Beginning Cash Position | 848,835 | 848,835 | 848,835 | 848,835 | 336,454 |
| End Cash Position | 285,038 | 752,469 | 792,151 | 824,280 | 848,835 |
| Net Cash Flow | $-563,797 | $-96,366 | $-56,684 | $-24,555 | $512,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | -111,193 | -84,020 | -54,324 | -24,002 | 513,140 |
| Capital Expenditure | -938 | -821 | -738 | -227 | -1,181 |
| Free Cash Flow | -112,131 | -84,841 | -55,062 | -24,229 | 511,959 |